Time-Restricted Eating in Menopause and HOrmone-sensitive Breast Cancers (TREMHO)

This study is aimed at women currently going through menopause, either as part of the natural process (physiological menopause), or following hormonal treatment for breast cancer. There are several ways of slowing the weight gain frequently encountered in this situation, reducing the intensity of menopause-related symptoms and improving quality of life in this context. In this trial, the investigators examine the efficacy and possible adverse effects of intermittent fasting compared with a control intervention. Participation lasts 14 weeks, with an optional 12-month follow-up. Study participa

Trial Details

NCT ID
NCT06855784
Phase
NA
Sponsor
University Hospital, Geneva
Status
RECRUITING
Cancer Type
Breast Cancer
Interventions
  • Time-Restricted Eating 16h/8h
  • Active Control
Locations (sample)
  • Geneva, Canton of Geneva, Switzerland|46.20222,6.14569

Key Eligibility Criteria

  • Women with confirmed physiological menopause without current anti-cancer treatment (group A), or women with menopausal symptoms in the context of a…
  • Age 40-65 years
  • Body mass index 25-40 kg/m2
  • Stable weight (± 2 kg) over the previous month

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →